RU95100307A - PHARMACEUTICAL PREPARATION OF ANTI-ALCOHOL AND NOOTROPIC ACTION - Google Patents

PHARMACEUTICAL PREPARATION OF ANTI-ALCOHOL AND NOOTROPIC ACTION

Info

Publication number
RU95100307A
RU95100307A RU95100307/14A RU95100307A RU95100307A RU 95100307 A RU95100307 A RU 95100307A RU 95100307/14 A RU95100307/14 A RU 95100307/14A RU 95100307 A RU95100307 A RU 95100307A RU 95100307 A RU95100307 A RU 95100307A
Authority
RU
Russia
Prior art keywords
alcohol
pharmaceutical preparation
nootropic action
vitamin
tablets
Prior art date
Application number
RU95100307/14A
Other languages
Russian (ru)
Other versions
RU2097034C1 (en
Inventor
И.А. Комиссарова
Ю.В. Гудкова
Т.Д. Солдатенкова
Н.М. Бурбенская
Т.Т. Кондрашова
Original Assignee
И.А. Комиссарова
Ю.В. Гудкова
Т.Д. Солдатенкова
Н.М. Бурбенская
Т.Т. Кондрашова
Filing date
Publication date
Application filed by И.А. Комиссарова, Ю.В. Гудкова, Т.Д. Солдатенкова, Н.М. Бурбенская, Т.Т. Кондрашова filed Critical И.А. Комиссарова
Priority claimed from RU9595100307A external-priority patent/RU2097034C1/en
Priority to RU9595100307A priority Critical patent/RU2097034C1/en
Priority to PCT/RU1996/000006 priority patent/WO1996021446A1/en
Priority to US08/704,745 priority patent/US5798371A/en
Priority to JP8521587A priority patent/JPH09510738A/en
Priority to DE19626431A priority patent/DE19626431B4/en
Priority to FR9608205A priority patent/FR2750605B1/en
Priority claimed from FR9608205A external-priority patent/FR2750605B1/en
Priority to CH01664/96A priority patent/CH691791A8/en
Publication of RU95100307A publication Critical patent/RU95100307A/en
Publication of RU2097034C1 publication Critical patent/RU2097034C1/en
Application granted granted Critical

Links

Claims (3)

1. Фармацевтический препарат антиалкогольного и ноотропного действия для сублингвального применения, характеризующийся тем, что в качестве активного начала он содержит аминокислоту треонин или ее фармацевтически приемлемую соль и витамин В12.1. Pharmaceutical preparation of anti-alcohol and nootropic action for sublingual use, characterized in that it contains the amino acid threonine or its pharmaceutically acceptable salt and vitamin B 12 as an active principle 2. Препарат по п. 1 в виде таблеток, характеризующийся тем, что он дополнительно содержит в качестве целевой добавки метилцеллюлозу и магний стеариновокислый. 2. The preparation according to claim 1 in the form of tablets, characterized in that it additionally contains methylcellulose and magnesium stearic acid as the target additive. 3. Препарат по пп. 1 и 2 в виде таблеток, характеризующийся тем, что он содержит активное начало и целевую добавку в следующих количествах на одну таблетку, г:
Треонин - 0,1-0,5
Витамина В12 - 0,005-0,08
Метилцеллюлоза - 0,001-0,005
Магний стеариновокислый - 0,001 - 0,0053. The drug on PP. 1 and 2 in the form of tablets, characterized in that it contains the active principle and the target additive in the following amounts per tablet, g:
Threonine - 0.1-0.5
Vitamin B 12 - 0.005-0.08
Methyl cellulose - 0.001-0.005
Stearic magnesium - 0.001 - 0.005
RU9595100307A 1995-01-13 1995-01-13 Pharmaceutical preparation showing antialcoholic and nootropic effects RU2097034C1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
RU9595100307A RU2097034C1 (en) 1995-01-13 1995-01-13 Pharmaceutical preparation showing antialcoholic and nootropic effects
PCT/RU1996/000006 WO1996021446A1 (en) 1995-01-13 1996-01-04 Pharmaceutical composition with anti-alcoholic and nootropic properties
US08/704,745 US5798371A (en) 1995-01-13 1996-01-04 Pharmaceutical composition endowed with an antialcoholic and nootropic effect
JP8521587A JPH09510738A (en) 1995-01-13 1996-01-04 Pharmaceutical composition with abstinence and nuotropic effect
DE19626431A DE19626431B4 (en) 1995-01-13 1996-07-01 Use of a pharmaceutical composition with anti-alcoholic and nootropic effect
FR9608205A FR2750605B1 (en) 1995-01-13 1996-07-02 PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS
CH01664/96A CH691791A8 (en) 1995-01-13 1996-07-03 PHARMACEUTICAL COMPOSITION AGAINST ALCOHOL MISUSE AND WITH NOTROPER EFFECT.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
RU9595100307A RU2097034C1 (en) 1995-01-13 1995-01-13 Pharmaceutical preparation showing antialcoholic and nootropic effects
DE19626431A DE19626431B4 (en) 1995-01-13 1996-07-01 Use of a pharmaceutical composition with anti-alcoholic and nootropic effect
FR9608205A FR2750605B1 (en) 1995-01-13 1996-07-02 PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS
CH01664/96A CH691791A8 (en) 1995-01-13 1996-07-03 PHARMACEUTICAL COMPOSITION AGAINST ALCOHOL MISUSE AND WITH NOTROPER EFFECT.

Publications (2)

Publication Number Publication Date
RU95100307A true RU95100307A (en) 1997-10-10
RU2097034C1 RU2097034C1 (en) 1997-11-27

Family

ID=27428256

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9595100307A RU2097034C1 (en) 1995-01-13 1995-01-13 Pharmaceutical preparation showing antialcoholic and nootropic effects

Country Status (5)

Country Link
JP (1) JPH09510738A (en)
CH (1) CH691791A8 (en)
DE (1) DE19626431B4 (en)
RU (1) RU2097034C1 (en)
WO (1) WO1996021446A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2097034C1 (en) * 1995-01-13 1997-11-27 Ирина Алексеевна Комиссарова Pharmaceutical preparation showing antialcoholic and nootropic effects
FR2750605B1 (en) * 1995-01-13 1998-09-25 Komissarova Irina Alexeevna PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS
RU2561063C1 (en) * 2014-07-01 2015-08-20 Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") Method for correcting neurological disturbances accompanying alcohol intoxication
JP2018127427A (en) * 2017-02-10 2018-08-16 味の素株式会社 Saliva secretion promoter, food composition containing the same, and oral composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405629A (en) * 1979-05-07 1983-09-20 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord
US4761429A (en) * 1985-07-22 1988-08-02 Kenneth Blum Enkephalinase and endorphinase inhibitors as anti-craving compositions
US5019558A (en) * 1988-05-09 1991-05-28 Georges Cehovic Method for treating memory disturbances using arginine aspartate
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
EP0575613B1 (en) * 1992-01-10 1998-07-22 KOMISSAROVA, Irina Alexeevna Use of the amino acid glycine for the preparation of a medicament with antistress-, stress-preventive and nootropic action
RU2097034C1 (en) * 1995-01-13 1997-11-27 Ирина Алексеевна Комиссарова Pharmaceutical preparation showing antialcoholic and nootropic effects

Similar Documents

Publication Publication Date Title
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
DK0797435T3 (en) Matrix for controlled release of drugs
DE59209706D1 (en) Medicines containing S (+) - ibuprofen
AR028299A1 (en) A PHARMACEUTICAL COMPOSITION THAT INCLUDES NATEGLINIDA, A PROCESS FOR ITS PREPARATION AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETY.
RU94041836A (en) Derivatives of amidine, mixture of their isomers or individual isomers and their salts, pharmaceutical composition exhibiting antagonistic activity with respect to leukotriene b4 activity
IT1294760B1 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL TABLETS ABLE TO RELEASE, ACCORDING TO PREDETERMINABLE SCHEMES, LITTLE ACTIVE INGREDIENTS
ID28735A (en) PHARMACEUTICAL PRESERVATION UNDER THE FREE DOUBLE UNIT AND THE PRODUCTION PROCESS
ATE158504T1 (en) EFFORTABLE MIXTURES CONTAINING IBUPROFEN AND METHODS
UA85359C2 (en) Tablet containing granulated material with kmd-3213
EA200001201A3 (en) Matrix tablet for prolonged release of trimetazidine
DE69716586D1 (en) BUFFERED ORTHOESTER POLYMERS CONTAINING MEDICINAL PRODUCTS
IT1270239B (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING ACID (S) -2- (4- ISOBUTYLPHENYL) PROPIONIC AS ACTIVE INGREDIENT
RU95100307A (en) PHARMACEUTICAL PREPARATION OF ANTI-ALCOHOL AND NOOTROPIC ACTION
CA2353693A1 (en) Pharmaceutical composition containing citalopram
MA27662A1 (en) PROCESS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS CONTAINING FIBRATE AND TABLETS OBTAINED ACCORDING TO THE PROCESS
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
RU93004535A (en) COMPOUNDS, METHOD OF OBTAINING AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
RU94019417A (en) METHOD FOR OBTAINING A PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL PREPARATION, METHODS OF OBTAINING A PHARMACEUTICAL PREPARATION
RU92004569A (en) PHARMACEUTICAL PRODUCT OF ANTI-STRESS, STRESS-PROTECTIVE AND NOOTROPIC ACTION
WO1997010810A3 (en) Pharmaceutical granules
FR2547730B1 (en) HYPOLIPIDEMIC DRUG CONTAINING AS ACTIVE INGREDIENT D-3-ACETOXY-CIS-2,3-DIHYDRO-5- (2- (DIMETHYLAMINO) ETHYL) -2- (P-METHOXYPHENYL) -1,5-BENZOTHIAZEPINE-4 (5H) -ONE OR ONE OF ITS SALTS OF ADDITION OF ACIDS ACCEPTABLE IN PHARMACY
US4086342A (en) 6-(1-Piperazinyl)morphanthridine as a sleep inducing or prolonging agent
BE898389R (en) Antiemetic compsns. contg. metoclopramide - also contain resin and water
ES8304924A1 (en) Peptide, process for preparation thereof and use thereof.
ATE303136T1 (en) ANHYDROUS DOUBLE-COATED TABLET CONTAINING RANITIDINE HYDROCHLORIDE AND COMPOSITION THEREOF